Press "Enter" to skip to content

New patent for Actelion drug OPSUMIT

0
Copyright © DrugPatentWatch. Originally published at New patent for Actelion drug OPSUMIT

Annual Drug Patent Expirations for OPSUMIT
Annual Drug Patent Expirations for OPSUMIT

Opsumit is a drug marketed by Actelion and is included in one NDA. It is available from one supplier. There are four patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for OPSUMIT.

This drug has eigthy-four patent family members in thirty-two countries.

The generic ingredient in OPSUMIT is macitentan. One supplier is listed for this compound. Additional details are available on the macitentan profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Actelion drug OPSUMIT
Online Certificate Course

Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

  • When will key drug patents expire?
  • How can I find, evaluate, and plan for generic market entry opportunities?
  • How can I find proprietary out-of-court settlements and deal terms?
DrugPatentWatch - Make Better Decisions